Author Title [ Type(Desc)] Year
Filters: Author is Tian, Xin  [Clear All Filters]
Journal Article
He J, Tian X, Luo T, Zou R, Yin Z, Chen K, Zhu C, He X. Allogeneic hematopoietic stem cell transplantation corrects ligase IV deficiency. Transpl Immunol. 2023:101897.
Zeng M, Chen K, Tian X, Zou R, Feng X, Li C, Li J, Zheng M, Mai H, Yang L, et al. Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group. Cancer Med. 2023.
Hu Y-H, Zhou P-F, Long G-F, Tian X, Guo Y-F, Pang A-M, Di R, Shen Y-N, De Liu Y-, Cui Y-J. Elevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with Thrombocytopenia. Med Sci Monit. 2015;21:3690-3695.
Zhao X, Tian X, Kajigaya S, Cantilena CR, Strickland S, Savani BN, Mohan S, Feng X, Keyvanfar K, Dunavin N, et al. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS. Br J Haematol. 2016.
Yu L, Tian X, Gao D, Lang Y, Zhang X-X, Yang C, Gu M-M, Shi J, Zhou P-K, Shang Z-F. Oral administration of hydroxylated-graphene quantum dots induces intestinal injury accompanying the loss of intestinal stem cells and proliferative progenitor cells. Nanotoxicology. 2019:1-13.
Jain P, Tian X, Cordes S, Chen J, Cantilena CR, Bradley C, Panjwani R, Chinian F, Keyvanfar K, Battiwalla M, et al. Over-expression of PD-1 does not predict leukemic relapse after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2018.
Lin P, Tian X, Wang X. Seizures after transplantation. Seizure. 2018;61:177-185.